Company / Operating Income
Chemed Corp. Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$338.2M
FY2025
5-year range
$338.2M / $366.5M
FY2021-FY2025
Trend
-7.7%
vs FY2024
Sector context
#45 of 151
Health Care
What the data says
At $338M, Chemed Corp.'s operating income ranks #45 of 151 in the Health Care sector. Operating Income has fluctuated over the past 10 years, ranging from $113M in FY2017 to $390M in FY2020.
Based on SEC 10-K filings.
$338M in FY2025 with a 5-year CAGR of -2.8%.
Remained stable around $338M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -0.5%
- 5-Year CAGR
- -2.8%
- 10-Year CAGR
- -
Sector benchmark
#45 of 151 in Health CareTop 30% of 151This company $338.2M Sector average $716.7M
▼
-52.8% below sector average
Key checks
Key Insights
- 5-year CAGR of -2.8%, indicating a declining trend.
- In FY2025, operating income decreased 7.7% year-over-year.
- Ranks #45 out of 151 companies in the Health Care sector.
- Peak operating income was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 4.70 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $338.2M | -7.7% |
| FY2024 | $366.5M | +7.6% |
| FY2023 | $340.6M | -0.9% |
| FY2022 | $343.5M | +0.1% |
| FY2021 | $343.0M | -12.0% |
| FY2020 | $389.7M | +51.4% |
| FY2019 | $257.4M | +5.6% |
| FY2018 | $243.6M | +115.5% |
| FY2017 | $113.0M | -36.8% |
| FY2016 | $178.7M | -3.1% |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026